| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | yes | yes: 7, no: 1 |
| NetGPI | no | yes: 0, no: 8 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 8 |
| GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: E9AK20
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 204 | 208 | PF00656 | 0.692 |
| CLV_C14_Caspase3-7 | 209 | 213 | PF00656 | 0.712 |
| CLV_NRD_NRD_1 | 177 | 179 | PF00675 | 0.409 |
| CLV_NRD_NRD_1 | 220 | 222 | PF00675 | 0.489 |
| CLV_NRD_NRD_1 | 76 | 78 | PF00675 | 0.553 |
| CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.675 |
| CLV_PCSK_KEX2_1 | 177 | 179 | PF00082 | 0.450 |
| CLV_PCSK_KEX2_1 | 220 | 222 | PF00082 | 0.489 |
| CLV_PCSK_KEX2_1 | 76 | 78 | PF00082 | 0.523 |
| CLV_PCSK_PC1ET2_1 | 148 | 150 | PF00082 | 0.589 |
| CLV_PCSK_PC1ET2_1 | 177 | 179 | PF00082 | 0.464 |
| DEG_Nend_UBRbox_4 | 1 | 3 | PF02207 | 0.419 |
| DEG_SPOP_SBC_1 | 114 | 118 | PF00917 | 0.308 |
| DEG_SPOP_SBC_1 | 232 | 236 | PF00917 | 0.571 |
| DOC_MAPK_RevD_3 | 162 | 178 | PF00069 | 0.361 |
| DOC_PP2B_LxvP_1 | 13 | 16 | PF13499 | 0.466 |
| DOC_USP7_MATH_1 | 16 | 20 | PF00917 | 0.451 |
| DOC_USP7_MATH_1 | 232 | 236 | PF00917 | 0.643 |
| DOC_USP7_MATH_1 | 66 | 70 | PF00917 | 0.351 |
| DOC_WW_Pin1_4 | 141 | 146 | PF00397 | 0.553 |
| DOC_WW_Pin1_4 | 38 | 43 | PF00397 | 0.382 |
| LIG_14-3-3_CanoR_1 | 220 | 225 | PF00244 | 0.715 |
| LIG_14-3-3_CanoR_1 | 76 | 81 | PF00244 | 0.320 |
| LIG_BRCT_BRCA1_1 | 213 | 217 | PF00533 | 0.671 |
| LIG_deltaCOP1_diTrp_1 | 75 | 80 | PF00928 | 0.344 |
| LIG_FHA_1 | 153 | 159 | PF00498 | 0.482 |
| LIG_FHA_1 | 49 | 55 | PF00498 | 0.332 |
| LIG_FHA_1 | 77 | 83 | PF00498 | 0.308 |
| LIG_FHA_2 | 124 | 130 | PF00498 | 0.404 |
| LIG_FHA_2 | 204 | 210 | PF00498 | 0.562 |
| LIG_LIR_Apic_2 | 141 | 146 | PF02991 | 0.455 |
| LIG_LIR_LC3C_4 | 51 | 55 | PF02991 | 0.227 |
| LIG_LIR_Nem_3 | 126 | 131 | PF02991 | 0.348 |
| LIG_LIR_Nem_3 | 79 | 83 | PF02991 | 0.300 |
| LIG_LYPXL_yS_3 | 131 | 134 | PF13949 | 0.326 |
| LIG_SH2_CRK | 143 | 147 | PF00017 | 0.493 |
| LIG_SH2_GRB2like | 128 | 131 | PF00017 | 0.358 |
| LIG_SH2_GRB2like | 137 | 140 | PF00017 | 0.337 |
| LIG_SH2_GRB2like | 71 | 74 | PF00017 | 0.338 |
| LIG_SH2_NCK_1 | 143 | 147 | PF00017 | 0.458 |
| LIG_SH2_SRC | 71 | 74 | PF00017 | 0.338 |
| LIG_SH2_STAP1 | 46 | 50 | PF00017 | 0.365 |
| LIG_SH2_STAT5 | 46 | 49 | PF00017 | 0.375 |
| LIG_SH2_STAT5 | 67 | 70 | PF00017 | 0.284 |
| LIG_SH2_STAT5 | 71 | 74 | PF00017 | 0.310 |
| LIG_SUMO_SIM_anti_2 | 155 | 160 | PF11976 | 0.298 |
| LIG_SUMO_SIM_par_1 | 121 | 126 | PF11976 | 0.208 |
| LIG_Vh1_VBS_1 | 158 | 176 | PF01044 | 0.295 |
| MOD_CDK_SPxxK_3 | 141 | 148 | PF00069 | 0.457 |
| MOD_CK1_1 | 189 | 195 | PF00069 | 0.712 |
| MOD_CK1_1 | 197 | 203 | PF00069 | 0.640 |
| MOD_CK1_1 | 208 | 214 | PF00069 | 0.651 |
| MOD_CK1_1 | 215 | 221 | PF00069 | 0.692 |
| MOD_CK1_1 | 222 | 228 | PF00069 | 0.643 |
| MOD_CK1_1 | 231 | 237 | PF00069 | 0.690 |
| MOD_CK2_1 | 222 | 228 | PF00069 | 0.684 |
| MOD_CK2_1 | 78 | 84 | PF00069 | 0.214 |
| MOD_Cter_Amidation | 146 | 149 | PF01082 | 0.628 |
| MOD_GlcNHglycan | 224 | 227 | PF01048 | 0.485 |
| MOD_GlcNHglycan | 230 | 233 | PF01048 | 0.453 |
| MOD_GlcNHglycan | 68 | 71 | PF01048 | 0.533 |
| MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.556 |
| MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.490 |
| MOD_GSK3_1 | 186 | 193 | PF00069 | 0.700 |
| MOD_GSK3_1 | 197 | 204 | PF00069 | 0.614 |
| MOD_GSK3_1 | 208 | 215 | PF00069 | 0.611 |
| MOD_GSK3_1 | 216 | 223 | PF00069 | 0.684 |
| MOD_GSK3_1 | 224 | 231 | PF00069 | 0.695 |
| MOD_GSK3_1 | 33 | 40 | PF00069 | 0.410 |
| MOD_GSK3_1 | 44 | 51 | PF00069 | 0.306 |
| MOD_GSK3_1 | 88 | 95 | PF00069 | 0.477 |
| MOD_GSK3_1 | 97 | 104 | PF00069 | 0.377 |
| MOD_N-GLC_1 | 138 | 143 | PF02516 | 0.716 |
| MOD_N-GLC_1 | 194 | 199 | PF02516 | 0.445 |
| MOD_NEK2_1 | 92 | 97 | PF00069 | 0.446 |
| MOD_NEK2_2 | 78 | 83 | PF00069 | 0.249 |
| MOD_PIKK_1 | 33 | 39 | PF00454 | 0.379 |
| MOD_PIKK_1 | 61 | 67 | PF00454 | 0.298 |
| MOD_PKA_1 | 220 | 226 | PF00069 | 0.686 |
| MOD_PKA_1 | 76 | 82 | PF00069 | 0.302 |
| MOD_PKA_2 | 219 | 225 | PF00069 | 0.680 |
| MOD_PKA_2 | 76 | 82 | PF00069 | 0.314 |
| MOD_Plk_1 | 194 | 200 | PF00069 | 0.591 |
| MOD_Plk_4 | 152 | 158 | PF00069 | 0.353 |
| MOD_Plk_4 | 212 | 218 | PF00069 | 0.651 |
| MOD_Plk_4 | 88 | 94 | PF00069 | 0.370 |
| MOD_ProDKin_1 | 141 | 147 | PF00069 | 0.553 |
| MOD_ProDKin_1 | 38 | 44 | PF00069 | 0.379 |
| MOD_SUMO_rev_2 | 17 | 22 | PF00179 | 0.346 |
| TRG_ENDOCYTIC_2 | 131 | 134 | PF00928 | 0.304 |
| TRG_ER_diArg_1 | 76 | 78 | PF00400 | 0.323 |
| TRG_NLS_MonoExtC_3 | 176 | 182 | PF00514 | 0.623 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1HRH3 | Leptomonas seymouri | 26% | 86% |
| A0A0N1PAN6 | Leptomonas seymouri | 26% | 83% |
| A0A0N1PBW5 | Leptomonas seymouri | 38% | 82% |
| A0A3S7WNP1 | Leishmania donovani | 84% | 98% |
| A4H3V9 | Leishmania braziliensis | 67% | 100% |
| A4HS33 | Leishmania infantum | 85% | 98% |
| Q9XZX6 | Leishmania major | 82% | 100% |